title: Small, dense LDL particle concentration correlates with plasminogen activator inhibitor type-1 (PAI-1) activity.
abstract: The relation between LDL subfractions and fibrinolytic activity was studied in 150 men aged 53 to 63 years. Apolipoprotein B (apoB) concentration in the most dense LDL-5 (r = 0.39, p <0.001) and LDL-6 (r = 0.43, p <0.001) subfractions associated with plasminogen activator inhibitor type-1 (PAI-1) activity. Subjects in the highest LDL-6 apoB tertile had higher PAI-1 (24.7 vs. 13.1 AU/ml, p <0.001) and lower t-PA (0.26 vs. 0.54 IU/ml, p <0.001) activities than men in the lowest tertile. The difference in PAI-1 remained after adjusting for either triglycerides (p = 0.039) or insulin (p = 0.015) with cardiorespiratory fitness as an additional covariate, and history of cardiovascular disease and smoking as factors. In a regression analysis, plasma insulin and LDL-6 apoB, but not plasma triglycerides and body mass index, entered the model, and explained 30.6 and 3.9% of the variance in PAI-1 activity, respectively. The novel finding of the present study was the independent association between small, dense LDL particles and PAI-1 activity in middle-aged men.
authors.affiliation: Department of Physiology, Kuopio University, Finland.
authors.forename: S
authors.initials: S
authors.lastname: Väisänen
authors.forename: M W
authors.initials: MW
authors.lastname: Baumstark
authors.forename: I
authors.initials: I
authors.lastname: Penttilä
authors.forename: C
authors.initials: C
authors.lastname: Bouchard
authors.forename: P
authors.initials: P
authors.lastname: Halonen
authors.forename: T
authors.initials: T
authors.lastname: Rankinen
authors.forename: A
authors.initials: A
authors.lastname: Berg
authors.forename: R
authors.initials: R
authors.lastname: Rauramaa
mesh_terms: D000704:Analysis of Variance; D000886:Anthropometry; D001055:Apolipoproteins B / Q000097:blood; D015992:Body Mass Index; D002318:Cardiovascular Diseases / Q000097:blood; D008078:Cholesterol, LDL / Q000097:blood; D015243:Cholesterol, VLDL / Q000097:blood; D005343:Fibrinolytic Agents / Q000097:blood; D006801:Humans; D007328:Insulin / Q000097:blood; D008077:Lipoproteins, LDL / Q000097:blood*; D008297:Male; D008875:Middle Aged; D010101:Oxygen Consumption / Q000502:physiology; D017395:Plasminogen Activator Inhibitor 1 / Q000097:blood*; D012044:Regression Analysis; D012907:Smoking / Q000097:blood; D010959:Tissue Plasminogen Activator / Q000097:blood; D014280:Triglycerides / Q000097:blood
chemical_list: D001055:Apolipoproteins B; D008078:Cholesterol, LDL; D015243:Cholesterol, VLDL; D005343:Fibrinolytic Agents; D007328:Insulin; D008077:Lipoproteins, LDL; D017395:Plasminogen Activator Inhibitor 1; D014280:Triglycerides; D010959:Tissue Plasminogen Activator